HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Radiotherapy of the neuroaxis for palliative treatment of leptomeningeal carcinomatosis.

AbstractBACKGROUND:
Leptomeningeal carcinomatosis occurs in about 5% of solid tumors and may seriously compromise quality of life. Aim of the present study was to evaluate the feasibility of craniospinal irradiation with and without intrathecal chemotherapy and its efficacy with regard to symptom palliation and survival.
PATIENTS AND METHODS:
16 patients (mean age 46 years; nine breast cancers, five lung cancers, one renal cell cancer, one tumor of unknown primary site) with leptomeningeal carcinomatosis occurring after a median interval from primary tumor diagnosis of 5 months (0-300 months) received craniospinal irradiation between October 1995 and May 2000. The median total dose was 36 Gy (à 1.6-2.0 Gy). Ten patients were additionally treated with intrathecal methotrexate (15 mg per cycle, 2-8 cycles).
RESULTS:
Median survival was 12 weeks, 8 weeks after radiotherapy alone, 16 weeks after combined modality treatment. 14 patients died from disease. Eleven patients (68%) experienced regression of their neurological symptoms during or soon after completion of radiotherapy. Seven patients regained their ability to walk, six had pain reduction, three regression of bladder and bowel incontinence. In three patients symptom progression and in two patients no change occurred. Side effects were: myelosuppression (CTC) Grade I: n = 2, Grade II: n = 4, Grade III: n = 4 patients and Grade IV: n = 1. Nine patients had dysphagia, seven mucositis, three suffered from nausea. No late toxicity was observed.
CONCLUSION:
Craniospinal radiotherapy is feasible and effective for palliative treatment of leptomeningeal carcinomatosis. As far as the small patient number permits any definite conclusions, combined modality treatment seems superior to irradiation alone.
AuthorsB Hermann, B Hültenschmidt, M L Sautter-Bihl
JournalStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (Strahlenther Onkol) Vol. 177 Issue 4 Pg. 195-9 (Apr 2001) ISSN: 0179-7158 [Print] Germany
PMID11370554 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Brain (drug effects, pathology)
  • Carcinoma (radiotherapy, secondary)
  • Combined Modality Therapy
  • Feasibility Studies
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Meningeal Neoplasms (radiotherapy, secondary)
  • Middle Aged
  • Palliative Care (methods)
  • Radiotherapy, Adjuvant
  • Retrospective Studies
  • Spine (drug effects, pathology)
  • Survival Analysis
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: